Intensive Care Med. 2008;34:895 902. 432. Haas NA, Camphausen CK. Impact of early and standardized treatment with amiodarone on therapeutic success and outcome in pediatric patients with postoperative tachyarrhythmia. J Thorac Cardiovasc Surg. 2008;136:1215 22. 433. Laird WP, Snyder CS, Kertesz NJ, et al. Use of intravenous amiodarone for postoperative junctional ectopic tachycardia in children. Pediatr Cardiol. 2003;24:133 7. 434. Kovacikova L, Hakacova N, Dobos D, et al. Amiodarone as a first-line therapy for postoperative junctional ectopic tachycardia. Ann Thorac Surg. 2009;88:616 22. 435. Walsh EP, Saul JP, Sholler GF, et al. Evaluation of a staged treatment protocol for rapid automatic junctional tachycardia after operation for congenital heart disease. J Am Coll Cardiol. 1997;29:1046 53. 436. van Engelen AD, Weijtens O, Brenner JI, et al. Management out- come and follow-up of fetal tachycardia. J Am Coll Cardiol. 1994;24: 1371 5. 437. Jaeggi ET, Carvalho JS, De Groot E, et al. Comparison of transplacen- tal treatment of fetal supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: results of a nonrandomized multicenter study. Circulation. 2011;124:1747 54. 438. van der Heijden LB, Oudijk MA, Manten GTR, et al. Sotalol as first- line treatment for fetal tachycardia and neonatal follow-up. Ultrasound Obstet Gynecol. 2013;42:285 93. 439. Strasburger JF, Cuneo BF, Michon MM, et al. Amiodarone therapy for drug-refractory fetal tachycardia. Circulation. 2004;109:375 9. 440. Bouchardy J, Therrien J, Pilote L, et al. Atrial arrhythmias in adults with congenital heart disease. Circulation. 2009;120:1679 86. 441. Bernier M, Marelli AJ, Pilote L, et al. Atrial arrhythmias in adult patients with right- versus left-sided congenital heart disease anomalies. Am J Cardiol. 2010;106:547 51. 442. Engelfriet P, Boersma E, Oechslin E, et al. The spectrum of adult congen- ital heart disease in Europe: morbidity and mortality in a 5 year follow-up period. 